Objective To study the prognosis of axillary node negative breast cancer patients.

目的对腋淋巴结阴性乳腺癌患者进行预后分析。

youdao

Objective To summarize the progress of clinical research on triple-negative breast cancer (TNBC).

目的综述三阴乳腺癌(TNBC)的临床研究进展。

youdao

All patients had lymph node-negative breast cancer and were postmenopausal at the time of diagnosis.

所有患者在确诊时均有淋巴结阴性乳腺癌以及处在绝经期。

youdao

Approved drugs for third-line use (meaning after two other drugs have been tried) in triple negative breast cancer only increase survival by 10% to 15%.

FORBES: Celldex Therapeutics Breast Cancer Drug Shows Strong Results In Some Patients

In patients with triple-negative breast cancer, a form of the disaese that responds to few existing drugs, none of the patients in the control group had a response.

FORBES: Celldex Therapeutics Breast Cancer Drug Shows Strong Results In Some Patients

On Friday the drug was approved for use in combination with Aromasin for postmenopausal women with recurring HER2-negative breast cancer, after treatment with the drugs Femara and Arimidex.

MSN: FDA approves Afinitor for some breast cancers